This site uses cookies to store information on your computer. By using this site, you consent to the placement and use of these cookies. Read our Privacy Policy to learn more. ACCEPT
Skip to content
Log In
 | 
Advertise
 | 
Subscribe
 | 
Contact Us

The Tablet The Tablet

  • News
    • Diocesan News
    • Schools News
    • New York News
    • National News
    • International News
  • Opinion
    • As The Tablet Sees It
    • Letters to the Editor
    • Columns
      • Faith & Thought
      • Up Front and Personal
      • Sunday Scriptures
      • Guest Columnists
  • Obituaries
  • Sports
  • Events
  • Newsletter
  • Support Us
    • Become a Member
    • Renew
    • Chasing Church News

REGN-COV2

‘Ethically’ Scrutinized COVID Drugs Pose Questions for Pro-Life Catholics

October 12, 2020

Catholic bioethicists express concern about developing COVID-19 vaccines or therapeutics using cell lines created from fetuses aborted nearly five decades ago. One such drug was praised recently by President Donald Trump, who said it cured him from his recent bout with COVID-19.

Bioethics Questions Emerge From Experimental Drug used in COVID-19 treatment

October 12, 2020

The treatment that President Donald Trump has received to fight COVID-19 has turned the focus on an experimental drug that shows promise in combating the coronavirus but is raising ethical questions about the cell line that helped researchers develop the medicine.

Thank you for reading The Tablet.

Create your free account or log in to continue reading.

Log In

Continue with Google
Continue with Facebook
Forgot password?

Sign Up

Register Today
The Tablet logo in page footer
Follow Us
Instagram Twitter Facebook

© 2026 DeSales Media Group, Inc. Website by 345 Design

  • Contact Us
  • Subscribe/Renew
  • Privacy Policy
  • Terms
  • Email Headlines

The Tablet is the newspaper of the Diocese of Brooklyn, serving Brooklyn and Queens since 1908.

Sign up for news headlines

Catholic Headlines Widget Signup
Name
Name

Your email will be used to send you The Tablet newsletter. You can unsubscribe at any time using the link in our emails. For more details, review our privacy policy. More info.